haemoglobin were recorded at 24-28 weeks of pregnancy. Results: Pre-pregnancy weight, Prepregnancy BMI, systolic and diastolic blood pressure, VLDL cholesterol and glucose parameters were higher in GDM compare with POT patients (p<0.05). VLDL Cholesterol, Triglycerides and Oral-Glucose-Tolerance-Test (OGTT) 2h were higher in Periodontitis patients compare with Non-Periodontitis patients (p<0.05). HbA 1c , Triglycerides, OGTT 1h and 2h were positively related with Probing Pocket Depth and Clinical Attachment Level; Blood glucose was related only with BOP (p<0.05). HbA 1c , OGTT basal, OGTT 1h and 2h were positively related with Pre-pregnancy BMI and blood pressure; HDL cholesterol was negatively related with Pre-pregnancy BMI; CRP was positively related with Pre-pregnancy BMI and diastolic blood pressure (p<0.05). Conclusions: Our data support the relationship between periodontal disease and some biochemical parameters such as lipid and glucose data in pregnancy, and also between MeS and biochemical parameters.
Periodontitis is a chronic infectious disease of the supporting tissues of teeth with multifactorial related factors ( 1 ). In recent years interest has grown regarding the relationship with other systemic conditions in order to identify some new aspects to improve our diagnostic tools and treatment outcomes ( 2 ). The bidirectional inter-relationship between diabetes and periodontal disease is one of the main issues ( 3 ). The term "diabetes mellitus" describes a group of disorders characterized by elevated levels of glucose in the blood and abnormalities of carbohydrate, fat and protein metabolism. Gestational diabetes mellitus (GDM) is defined as a type of diabetes first diagnosed during pregnancy ( 4 ). Incidence of GDM varies from 2% to 14% globally and is increasing ( 5 ). It is associated with the risk of perinatal morbidity, and a later development of pathology in offspring and mothers. Borderline GDM has been linked with pathogenesis in the offspring of overweight and Metabolic Syndrome (MeS) patients ( 6 ) . MeS consists of a combination of impaired glucose regulation, abdominal obesity, dyslipidemia, and high blood pressure ( 7 ) . It is estimated that around a quarter of the world's adult population is affected by MeS ( 8 ) . It is generally accepted that the origin is a "pro-inflammatory" state derived from excessive calorie intake and overnutrition and other chronic inflammatory diseases. Oxidative stress has been proposed as a potential common link to explain relationships between each component of MeS and periodontitis ( 9 ) . Intrauterine exposure to GDM has been associated with a small increase in adiposity at age 3 which may mediate the higher blood pressure in these children ( 10 ).
MeS is a risk factor for Cardiovascular Disease (CVD) and for diabetes. GDM women have a markedly elevated risk (adjusted hazard ratio 1.71) for CVD that manifests 11 years after pregnancy ( 11 ) . Furthermore, population-based administrative data has shown that, by 12 years postpartum, even women with mildly abnormal antepartum glucose tolerance have an increased risk of CVD, lower than that associated with GDM but significantly higher than that of women who maintain normal glucose tolerance in pregnancy ( 12 ). Since CVD represents the clinical manifestation of a chronic pathological process (atherosclerosis) that develops over decades, the risk factors contributing to the gradient of future cardiovascular risk associated with gestational dysglycemia are likely to be longstanding and present at the time of pregnancy or shortly thereafter. Furthermore, women with GDM are at increased risk of developing type 2 diabetes ( 13 ). A recent systematic review and meta-analysis concluded that women who have had GDM have at least a seven-fold increased risk of developing type 2 diabetes mellitus in the future compared with those who have had a normoglycaemic pregnancy ( 14 ) .
Most pregnant women have problems with their gums, especially gingivitis ( 15 ). The association between periodontitis and GDM has been described ( 16 ) .
Pregnancy is often the first time the body suffers from metabolic stress conditions or periodontal changes and both diseases should be diagnosed. The association between all the clinical and biochemical MeS parameters in Gestational Glucose Metabolism Disorder has not yet been completely studied. Therefore we tried to establish the relationship of those parameters with periodontal conditions in pregnant women affected by Gestational Glucose Metabolism Disorder.
MATERIAL AND METHODS

Patients and Study Design
Between October 2007 and December 2010, 982 pregnant women who attended an Obstetric Clinic in Seville were investigated to rule out GDM at 24-28 weeks of gestation via a 2-step process (screening test and then a diagnostic test). The screening O´Sullivan test ( 17 ) was a nonfasting oral glucose challenge test, in which venous blood was sampled 1 h after a 50 g oral glucose load. When this screening test showed blood glucose value of ≥140 mg/dl or lower than 200 mg/dl the women were considered as positive for the O´Sullivan test (POT). They were referred to the Hospital "Virgen Macarena" in Seville (Spain) for an oral glucose tolerance test (OGTT) to confirm if they were GDM. We recruited these women and invited them to participate in the study. They all met the following inclusion criteria: gestation with ≤ 32 weeks, ≥ 18 years old, ≥ 20 teeth present, no systemic disease and no medical treatment in the last 6 months. All pregnant women provided written informed consent, previously approved by the University Ethic Committee and conducted in agreement with the Declaration of Helsinki ( 18 ).
Periodontal Parameters
All the periodontal records were assessed at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) for all teeth present (excluding third molars). Mean number of sites positive for plaque (PLQ) and bleeding on probing (BOP) were obtained for each patient ( 19 ) . Probing pocket depth (PD) was measured from the gingival margin to the most apical penetration of the probe; recession was measured from the cementoenamel junction to the gingival margin. They were recorded to the nearest millimetre using a PSP12 probe * by one examiner (PB). He has been calibrated for reproducibility prior to the study with the first 10 patients; an intraclass correlation coefficient of 92% was calculated for PD. Clinical attachment level (CAL) was defined as the algebraic sum of PD and gingival recession. According to the criteria established by Page&Eke ( 20 ) periodontitis (PER) was defined on the presence of ≥2 interproximal sites with CAL ≥6 mm (not on the same tooth) and ≥1 interproximal site with PD ≥5 mm.
Clinical Parameters
Mother´s age, Pre-pregnancy Weight and Height were recorded in the first obstetrical visit, not later than 8 wks of pregnancy. Pre-pregnancy Body Mass Index (BMI) was calculated. Blood pressure was measured with the patient seated and relaxed for 5 minutes, using aneroid devices two measurements were taken and the second one was recorded.
Biochemical Parameters
Blood samples were collected after 12 hours of fasting by venipuncture. Whole blood specimens were collected in different tubes † to obtain serum. All samples were immediately centrifuged at 3,500 rpm for 7 min at 4 ºC. Serum samples were separated in aliquots (1 ml) and were stored at -80 ºC until assayed. Glucose, C-reactive protein (CRP), triglycerides, total cholesterol, LDL-c, HDL-c and VLDL-c cholesterol levels were measured using enzymatic methods in a random access analyser (Advia 2400 Siemens Healthcare). Blood for HbA1c was collected in ethylenediaminetetraacetic acid vials and estimated by highperformance liquid chromatography-based ion exchange chromatography ‡ .
Oral glucose tolerance test (OGTT)
. A diagnosis of GDM was then made if ≥2 values on the 3-h OGGT were above reference limits (National Diabetes Data Group criteria): fasting>95 mg/dl, 1h>180 mg/dk, 2 h>155 mg/dl, 3 h>140 mg/dl ( 21 ).
Statistical Analysis
A previous pilot study had been performed. To detect a 6 units of difference between pregnant women with and without PER, 5% α error and 80% statistical power we need 12 patients in each group. This sample size is also adequate to compare HbA1c between both groups (5% α error, 80% statistical power, 0.4 variability and a minimum difference of 0.5 to be detected). Analysis included descriptive statistics: mean and standard deviations of continuous data and percentage and frequency of categorical data. Student´s t-test and the Mann Whitney U-test were used depending on the data normality. Shapiro-Wilk test was applied for normality screening and was not significant (p>0.05). Pearson coefficient corre lation was calculated to quantify the relationship between numerical variables. Statistical concordance between different measurements was calculated with intraclass correlation coefficient and 95% confidence interval. All the clinical and biochemical characteristics related with GDM were identified with a binomial logistic regression model. A significance level of p< 0.05 was adopted.
RESULTS
249 POT women were invited to participate in the study, 26 declined participation, 29 were excluded due to lack e data. A total of 188 women were included, 26 of them diag of gestational data and 6 due to lack of glucos nosed as GDM and 162 as POT.
Periodontal Disease and diabetic conditions were related to periodontitis (Table 1) . PER was diagnosed in 15.4% (n=4) and No-PER in 84.6% (n=22) of GDM, in POT PER was diagnosed in a smaller proportion PER in 5.6% (n=9) and No-PER in 94.4% (n=153) patients, but differences were not statistically significant (p=0.086). 23 women (12,2%) declared tobacco consumption
The clinical characteristics (MeS parameters and periodontal data) were related with periodontitis and diabetic conditions ( Table 2 ). All the clinical parameters were not statistically different in PER. The values of periodontal measurements were higher in PER just for BOP (p=0.001). Pre-pregnancy weight, Prepregnancy BMI, systolic and diastolic blood pressure were higher in GDM (p<0.05). The values of periodontal measurements were higher in GDM just for PLQ (p=0.003).
Biochemical MeS parameters were related to periodontal conditions and glucose metabolism status (Table 3) . Biochemical MeS parameters were higher in PER women but only statistically significant (p<0.05) for VLDL cholesterol, Triglycerides, OGTT 1h and OGTT 2 h. All the biochemical MeS parameters according to the glucose metabolism status were higher in GDM women but only statistically significant (p<0.05) for HbA 1c , VLDL cholesterol, OGTT basal, OGTT 1 h, OGTT 2h and OGTT 3 h.
The binomial logistic regression model showed that the association between clinical and biochemical variables of pregnant women according to diabetic conditions adjusted by periodontal status was maintained (Table 4) .
We studied the correlation between periodontal and biochemical MeS parameters (Table 5 ). HbA 1c was correlated positively with all the periodontal parameters; blood glucose with BOP; triglycerides with PD and CAL; OGTT 1 h and OGTT 2 h with PD, CAL and PLQ. In all the parameters the correlation coefficient are relatively low.
The positive statistically significant correlation between clinical and biochemical MeS parameters has been showed (Table 6 ). HbA 1c , OGTT Basal and OGTT 1h correlated positively with all the clinical MeS parameters. OGTT 2 h correlated positively with all the parameters except for P-Weight. HDL correlated negatively with P-Weight and P-BMI. CRP correlated positively with P-Weight, P-BMI and Diastolic BP.
DISCUSSION
Our data support the relationship between periodontal disease and some biochemical parameters such as lipid and glucose data in pregnancy, also between clinical MeS and biochemical parameters. Some limitations should be highlighted in our study. We selected patients at the hospital, this could introduce a recruitment bias ( 22 ), but it is the best way to obtain a representative population. In our region all the pregnant women has to go to the gynaecologist and it is the best way to recruit them. Periodontitis and type 2 diabetes mellitus has been diagnosed in patients older than our group of patients ( 23 ) and also our pregnant women had good systemic health. These could be the reasons why our patients had a low rate of periodontitis, only 13 from out of a total of 188 patients.
Cardiovascular disease is the leading cause of death among women; thus, identifying early markers of increased risk, prior to either subclinical progressive cardiovascular disease or morbid events, would facilitate targeted initiation of preventative health strategies early on ( 24 ). Glucose metabolism disorder, MeS and periodontitis has been related ( 9 ) and could be the underlying risk conditions. Nowadays the best ways to control diabetes and periodontitis is prevention and identification of the high-risk population ( 25 , 26 ). One of the possibilities is to control pregnancy screening the metabolic status, as this could be the first time that women suffer from high metabolic stress, and the whole body is involved in sustaining the new growing baby. Therefore our paper tries to give new data to support the early diagnosis of MeS, Glucose Metabolism Disorder and periodontal conditions in order to prevent future development of diabetes and periodontitis.
As previously stated, diabetes and periodontitis are related ( 27 ), but we had no statistical difference in the proportion of periodontitis between the GDM and the POT group. This could be due to the young age of our pregnant women. Periodontal disease is associated with an increased risk of GDM, and there is a doseresponse relationship of increased GDM risk with increasing severity of periodontal disease ( 28 ), though other authors found an increase of clinical periodontal disease in women with GDM but not in those without GDM, although this increase did not reach statistical significance ( 29 ) . A prospective study in an adult population aimed to develop a targeted identification protocol for unrecognized hyperglycaemia indicates that a simple algorithm composed of only 2 dental parameters (number of missing teeth and percentage of deep periodontal pockets) is effective in identifying dental patients with unrecognized pre-diabetes or diabetes ( 30 ) . Therefore periodontal data in our pregnant women could help us to make an early diagnosis of Glucose Metabolism Disorder.
For the GDM diagnosis we used the recommendation made by the American College of Obstetricians and Gynecologists ( 31 ) for pregnant women. O`Sullivan screening test was used initially, if it was positive, OGTT was performed. We obtain two groups of patients: one suffering GDM and the other positive O`Sullivan patients. For the gynecologist a positive O`Sullivan can be consider as healthy women. This test is just considered as a screening test that should be confirmed with an OGTT to be diagnosed as a Glucose Metabolism disorder ( 32 ).
These results could be other consequences of our type of patients, there are young and healthy for type2 diabetes and periodontitis. But the data can be considered as early and indicative of future development of the disease. Our data showed HbA 1c related to all periodontal and clinical MeS parameters. HbA 1c has been included in the diagnostic criteria of diabetes this year ( 4 ) and its ability to identify individuals with a high future risk for developing diabetes has been demonstrated ( 33 ). In the general population a positive correlation was found between PD and HbA 1c ( 34 ) and periodontitis is associated with significantly higher HbA 1c and fasting glucose levels ( 35 ) . In a large 5-year case-control cohort study, a positive relationship was found between developing periodontal disease in people with different HbA 1c -levels and between the incidence of elevated HbA 1c levels and periodontal disease ( 36 ). Age and HbA 1c were factors related to CAL in GDM ( 37 ). Also our triglyceride and OGTT data showed a relationship with PD and CAL. These results agree with previous data ( 38 ) and could imply a relationship between early alveolar bone loss and the development of metabolic syndrome in pregnancy. Blood Glucose was related with BOP in our patients according to the literature which shows high values in all pregnant patients in diabetic groups ( 35 ) . We demonstrated a confluence of clinical MeS conditions such as hypertension, P-weight and P-BMI with glucose metabolism data. A quantitative review of prospective studies examining the association between MeS and incident diabetes demonstrated a strong association between the two ( 39 ). Maternal obesity is a risk factor for complications, regardless of diabetes status ( 40 , 41 ) and the probability of increased GDM with increasing BMI has been demonstrated for all racial/ethnic groups ( 42 ). The obese woman is at risk for a multitude of potential medical and obstetric problems during gestation, which may have adverse short-term effects on her fetus. Obese women are at significant risk for gestational hypertension, pre-eclampsia and gestational diabetes (GDM). The adjusted odds ratio (OR) for the risk of GDM was 2.6 for obese and 4.0 for morbidly obese women, respectively ( 43 ). The Fifth International Workshop-Conference on GDM classifies severe obesity as a high risk-factor for GDM and recommends OGTT or oral glucose challenge test (OGCT) as soon as feasible and repeated at 24-28 weeks if GDM is not diagnosed ( 44 ).1-h OGTT predicts an enhanced postpartum cardiovascular risk factor profile among women without GDM, and in young women with mild dysglycemia in pregnancy, those with 1-h OGTT may include an unrecognized patient population at risk for future cardiovascular disease ( 45 ).
Our HDL data demonstrated a correlation between low levels with P-Weight and P-BMI. High-density lipoprotein (HDL) is one of the five major groups of lipoproteins, which enable lipids like cholesterol and triglycerides to be transported within the bloodstream. Reduced plasma HDL levels are a key feature of the metabolic syndrome, a clinical entity known to be a predisposing factor for atherosclerotic heart disease and type 2 diabetes ( 46 ).
CRP is regarded as a biomarker of systemic inflammation; it has been related to periodontitis ( 47 ) and can predict the development of type 2 diabetes ( 48 ). Early systemic inflammation in pregnancy, as measured by a C-reactive protein level, was studied in women with maternal periodontal disease and an increased risk for the development of preeclampsia was found ( 49 ). C-reactive protein may be an explanatory variable in the linkage between periodontal disease and preeclampsia. We could not demonstrate this relationship; this could be due to the good periodontal conditions of our patients or to racial conditions, our patients are white women. Maternal periodontal disease was associated with CRP, among African American women but not among white women ( 50 ) . Our data demonstrate a correlation between CRP, metabolic syndrome and obesity in pregnancy like the one reported in the literature for the non-pregnant population ( 51 , 52 ). These findings have important implications for the screening of obesity in pregnant women.
Our data suggests that in pregnant women periodontitis is associated with some glucose and lipid parameters, and MeS parameters are related to glucose, lipid and CRP parameters, however to confirm our statements further studies should be performed. Pregnancy could be the first time in which the body suffers from metabolic stress conditions and periodontal and MeS parameters could start developing in these women, therefore they should be carefully controlled to prevent the future appearance of pathologies such as periodontitis, diabetes and cardiovascular diseases both in the mother and offspring.
ACKNOWLEDGMENTS:
The study was supported by "Help for Research Group CTS 113, Andalusia Regional Administration, Spain". The authors declare that there are no conflicts of interest in this study. 
